Intensity Therapeutics | 8-K: Current report
Apr 20 04:07
Intensity Therapeutics | 8-K: Current report
Mar 15 04:20
Intensity Therapeutics | 10-K: Annual report
Mar 15 04:06
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Wesolowski John M
Mar 8 07:11
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Leahy Emer
Mar 8 07:06
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GOLDBERG MARK A
Mar 8 07:06
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Donovan Daniel
Mar 8 07:06
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer BENDER LEWIS H
Mar 8 07:06
Intensity Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lewis H. Bender(16.1%)
Feb 14 11:25
Intensity Therapeutics | 8-K: Current report
Feb 8 05:18
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Talamo Joseph
Dec 12, 2023 21:17
Intensity Therapeutics | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer Talamo Joseph
Dec 12, 2023 21:15
Intensity Therapeutics | 8-K: Current report
Dec 12, 2023 21:02
Intensity Therapeutics | 8-K: Current report
Nov 23, 2023 05:30
Intensity Therapeutics | 10-Q: Quarterly report
Nov 14, 2023 01:10
Intensity Therapeutics | 8-K: Intensity Therapeutics Reports Third Quarter Financial Results and Provides Corporate Update
Nov 13, 2023 21:02
Intensity Therapeutics | 8-K: Current report
Sep 5, 2023 20:05
Intensity Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Aug 23, 2023 03:37
Intensity Therapeutics | 10-Q/A: Quarterly report (Amendment)
Aug 15, 2023 05:25
Intensity Therapeutics | 10-Q: Quarterly report
Aug 15, 2023 00:45
No Data
No Data